CHEMOKINES AND IMMUNE CELLS IN HIND LIMB ISCHEMIA

后肢缺血中的趋化因子和免疫细胞

基本信息

项目摘要

DESCRIPTION (provided by applicant): Muscle regeneration and angiogenesis are important components of limb salvage following traumatic and/or ischemic injury to the extremities. We have demonstrated that knockout mice lacking either monocyte chemotactic protein-1 (MCP-1) or its specific receptor, the CC Chemokine Receptor 2 (CCR2), have impairments in macrophage recruitment and muscle regeneration following ischemic or toxic injury. In addition, CCR2-/- mice exhibit increased adipocyte accumulation in regenerated muscle. Bone marrow (BM) replacement of CCR2 -/- mice with wild type (WT) BM (radiation chimeras) led to increased early macrophage recruitment and normal muscle regeneration (i.e., recapitulated the phenotype of WT mice). Furthermore, replacing the BM of WT mice with CCR2 -/- BM resulted in decreased macrophage recruitment and impaired muscle regeneration (i.e., recapitulated the phenotype of CCR2 -/- mice). This suggests that BM-derived cells modulate the healing responses of muscle and that macrophages are the likely BM-derived cell type that mediates the impaired muscle regeneration in CCR2 -/- mice. Further studies revealed impaired angiogenesis in CCR2 -/- mice in conjunction with decreased tissue vascular endothelial growth factor (VEGF) compared to WT mice. Interestingly, restoration of VEGF to baseline levels was associated with the development of maximal capillary density in both CCR2 -/- and WT mice. While impaired muscle regeneration in CCR2 -/- mice is attributable to a BM-derived cell, the effects of BM-derived vs. host-derived cells have not been studied in regards to angiogenesis. Our long-term goal is to define the influence of inflammation, including the chemokine system, in angiogenesis and skeletal muscle regeneration. The following 3 specific aims will test the overall hypothesis that the recruitment and activation of BM-derived cells, especially monocytes/macrophages, are essential for angiogenesis, a critical component in skeletal muscle regeneration after injury. 1) Determine the contribution of CCR2 expression in BM-derived vs. non-BM- derived cells on angiogenesis in skeletal muscle after injury, 2) Determine the ex vivo and in vivo influence of the MCP-1/CCR2 axis on angiogenesis and 3) Define the effects of selective and complete monocyte/macrophage ablation prior to muscle injury and sustained throughout the time course of tissue repair on inflammation and angiogenesis after injury. The proposed studies are innovative because they will help define the contribution of BM-derived cells to angiogenesis. The significance of this research is that a better understanding of the mechanisms of skeletal muscle regeneration and angiogenesis could lead to the design of novel primary or adjuvant treatments for improved limb salvage and tissue engineering. PUBLICE HEALTH RELEVANCE: Leg and arm wounds, with large muscle defects and high amputation rates, are common in trauma victims and especially in injured soldiers from the Iraqi/Afghanistan war; new treatments to replace the missing muscle are needed to decrease amputation rates and improve limb function. Our research studies the complex relationships between the multiple cells that are needed to make new muscle, including blood vessels. A better understanding of how new blood vessels help muscle recover from injury could lead to new therapies, including tissue engineering strategies, to help patients recover from these devastating injuries.
描述(由申请人提供):肌肉再生和血管生成是四肢创伤和/或缺血性损伤后保肢的重要组成部分。我们已经证明,缺乏单核细胞趋化蛋白-1 (MCP-1) 或其特异性受体 CC 趋化因子受体 2 (CCR2) 的基因敲除小鼠,在缺血或中毒性损伤后巨噬细胞募集和肌肉再生方面会受到损害。此外,CCR2-/-小鼠在再生肌肉中表现出脂肪细胞积累增加。用野生型 (WT) BM(放射嵌合体)替代 CCR2 -/- 小鼠的骨髓 (BM) 导致早期巨噬细胞募集增加和正常肌肉再生(即重现 WT 小鼠的表型)。此外,用 CCR2 -/- BM 替换 WT 小鼠的 BM 会导致巨噬细胞募集减少和肌肉再生受损(即重现 CCR2 -/- 小鼠的表型)。这表明骨髓来源的细胞调节肌肉的愈合反应,并且巨噬细胞可能是介导 CCR2 -/- 小鼠受损肌肉再生的骨髓来源的细胞类型。进一步的研究表明,与 WT 小鼠相比,CCR2 -/- 小鼠的血管生成受损,并且组织血管内皮生长因子 (VEGF) 减少。有趣的是,在 CCR2 -/- 和 WT 小鼠中,VEGF 恢复至基线水平与最大毛细血管密度的发展相关。虽然 CCR2 -/- 小鼠的肌肉再生受损可归因于 BM 衍生细胞,但尚未研究 BM 衍生细胞与宿主衍生细胞对血管生成的影响。我们的长期目标是确定炎症(包括趋化因子系统)对血管生成和骨骼肌再生的影响。以下 3 个具体目标将检验总体假设,即骨髓衍生细胞(尤其是单核细胞/巨噬细胞)的招募和激活对于血管生成至关重要,而血管生成是损伤后骨骼肌再生的关键组成部分。 1) 确定 BM 衍生细胞与非 BM 衍生细胞中 CCR2 表达对损伤后骨骼肌血管生成的贡献,2) 确定 MCP-1/CCR2 轴对血管生成的体外和体内影响,以及 3 )定义肌肉损伤前选择性和完全单核细胞/巨噬细胞消融以及在组织修复过程中持续的对损伤后炎症和血管生成的影响。拟议的研究具有创新性,因为它们将有助于确定骨髓来源的细胞对血管生成的贡献。这项研究的意义在于,更好地了解骨骼肌再生和血管生成的机制可能有助于设计新的主要或辅助治疗,以改善保肢和组织工程。公共健康相关性:腿部和手臂伤口具有较大的肌肉缺陷和较高的截肢率,在创伤受害者中很常见,特别是在伊拉克/阿富汗战争中受伤的士兵中;需要新的治疗方法来替代缺失的肌肉,以降低截肢率并改善肢体功能。我们的研究研究了制造新肌肉(包括血管)所需的多个细胞之间的复杂关系。更好地了解新血管如何帮助肌肉从损伤中恢复可能会带来新的疗法,包括组织工程策略,以帮助患者从这些毁灭性损伤中恢复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAULA K SHIREMAN其他文献

PAULA K SHIREMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAULA K SHIREMAN', 18)}}的其他基金

Harnessing the power of CTSA-CDRN data networks: Using social determinants of health, frailty and functional status to identify at-risk patients and improve risk adjustment
利用 CTSA-CDRN 数据网络的力量:利用健康、虚弱和功能状态的社会决定因素来识别高危患者并改善风险调整
  • 批准号:
    9981049
  • 财政年份:
    2018
  • 资助金额:
    $ 37.1万
  • 项目类别:
Harnessing the power of CTSA-CDRN data networks: Using social determinants of health, frailty and functional status to identify at-risk patients and improve risk adjustment
利用 CTSA-CDRN 数据网络的力量:利用健康、虚弱和功能状态的社会决定因素来识别高危患者并改善风险调整
  • 批准号:
    10199784
  • 财政年份:
    2018
  • 资助金额:
    $ 37.1万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10221553
  • 财政年份:
    2015
  • 资助金额:
    $ 37.1万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10455763
  • 财政年份:
    2015
  • 资助金额:
    $ 37.1万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10670119
  • 财政年份:
    2015
  • 资助金额:
    $ 37.1万
  • 项目类别:
MicroRNA Regulation of Macrophage Polarization in Muscle Regeneration
肌肉再生中巨噬细胞极化的 MicroRNA 调节
  • 批准号:
    8598034
  • 财政年份:
    2011
  • 资助金额:
    $ 37.1万
  • 项目类别:
MicroRNA Regulation of Macrophage Polarization in Muscle Regeneration
肌肉再生中巨噬细胞极化的 MicroRNA 调节
  • 批准号:
    8240594
  • 财政年份:
    2011
  • 资助金额:
    $ 37.1万
  • 项目类别:
MicroRNA Regulation of Macrophage Polarization in Muscle Regeneration
肌肉再生中巨噬细胞极化的 MicroRNA 调节
  • 批准号:
    8391644
  • 财政年份:
    2011
  • 资助金额:
    $ 37.1万
  • 项目类别:
Chemokines and Immune Cells in Hind Limb Ischemia
后肢缺血中的趋化因子和免疫细胞
  • 批准号:
    6935939
  • 财政年份:
    2003
  • 资助金额:
    $ 37.1万
  • 项目类别:
CHEMOKINES AND IMMUNE CELLS IN HIND LIMB ISCHEMIA
后肢缺血中的趋化因子和免疫细胞
  • 批准号:
    7856125
  • 财政年份:
    2003
  • 资助金额:
    $ 37.1万
  • 项目类别:

相似国自然基金

AGEs-RAGE轴诱导的肝细胞衰老促进糖尿病合并非酒精性脂肪性肝病进展的机制研究
  • 批准号:
    82300914
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
  • 批准号:
    82300966
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
去势环境下CAF来源的CREB3L4通过增强癌细胞脂肪酸合成促进前列腺癌转移的机制研究
  • 批准号:
    82303434
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
运动促进脂肪细胞释放富含miR-17-3p的外泌体及靶向调控CAMKII介导心脏保护的作用机制研究
  • 批准号:
    82302875
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Kallistatin抑制管周脂肪细胞线粒体裂变拮抗动脉粥样硬化的作用及机制研究
  • 批准号:
    82370443
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Investigating mechanisms of chemoresistance in triple-negative breast cancer
研究三阴性乳腺癌的化疗耐药机制
  • 批准号:
    10747715
  • 财政年份:
    2022
  • 资助金额:
    $ 37.1万
  • 项目类别:
Investigating mechanisms of chemoresistance in triple-negative breast cancer
研究三阴性乳腺癌的化疗耐药机制
  • 批准号:
    10549343
  • 财政年份:
    2022
  • 资助金额:
    $ 37.1万
  • 项目类别:
Investigating the Metabolic Reprogramming of Ovarian Tumors During Omental Metastasis
研究卵巢肿瘤大网膜转移期间的代谢重编程
  • 批准号:
    10328248
  • 财政年份:
    2021
  • 资助金额:
    $ 37.1万
  • 项目类别:
Metabolic reprogramming of the tumor microenvironment and therapy resistance
肿瘤微环境的代谢重编程和治疗抵抗
  • 批准号:
    10683721
  • 财政年份:
    2021
  • 资助金额:
    $ 37.1万
  • 项目类别:
Regenerative Lipid Mediators for the Management of Severe Burn Wounds
用于治疗严重烧伤创面的再生脂质介质
  • 批准号:
    10576811
  • 财政年份:
    2020
  • 资助金额:
    $ 37.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了